Evidence map›Paper›PMID 42353554›Full record

ArticleCurrent issues in molecular biology2026

Olive Leaf Extract Suppresses Sebogenesis and Inflammation via AKT/ERK and SREBP-1/PPAR-γ Signaling in Human Sebocytes.

Jeeyoung Kim, Ye-Won Jo, Weon Jeong Bang, Kwang Won Lee, Yung Hyup Joo, Sung Hyeon Lee, Chang-Seok Lee

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeeyoung KimResearch and Development Center, Durae Corporation, Anyang Trade Center 14F, 161, Simin-daero, Dongan-gu, Anyang 14048, Gyeonggi-do, Republic of Korea.
Ye-Won JoDepartment of Senior Healthcare, Eulji University, Sujeong-gu, Seongnam 13135, Gyeonggi-do, Republic of Korea.
Weon Jeong BangResearch and Development Center, Durae Corporation, Anyang Trade Center 14F, 161, Simin-daero, Dongan-gu, Anyang 14048, Gyeonggi-do, Republic of Korea.
Kwang Won LeeResearch and Development Center, Durae Corporation, Anyang Trade Center 14F, 161, Simin-daero, Dongan-gu, Anyang 14048, Gyeonggi-do, Republic of Korea.
Yung Hyup JooResearch and Development Center, Durae Corporation, Anyang Trade Center 14F, 161, Simin-daero, Dongan-gu, Anyang 14048, Gyeonggi-do, Republic of Korea.
Sung Hyeon LeeResearch and Development Center, Durae Corporation, Anyang Trade Center 14F, 161, Simin-daero, Dongan-gu, Anyang 14048, Gyeonggi-do, Republic of Korea.
Chang-Seok LeeDepartment of Senior Healthcare, Eulji University, Sujeong-gu, Seongnam 13135, Gyeonggi-do, Republic of Korea.ORCID 0000-0002-4814-5685

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated olive leaf extract (OLE) as a multifunctional dermocosmetic candidate for sebum-related and inflammatory responses relevant to oily and acne-prone skin using an axis-aligned in vitro panel: (i) sebocyte lipogenesis, (ii) inflammatory mediator production in keratinocytes, and (iii) fibroblast-mediated collagen gel contraction. In addition, supportive mechanistic evidence for the sebum-related effects of OLE was obtained by examining signaling proteins associated with sebocyte lipogenesis, including PPAR-γ and SREBP-1. As a result, OLE significantly inhibited linoleic acid-induced lipid accumulation in SEB-1 sebocytes without cytotoxicity. In HaCaT keratinocytes, OLE significantly reduced the production of pro-inflammatory cytokines, including IL-8, TNF-α, and PGE

Indexed as

collagen gel contractionCutibacterium acnesdermal remodelinginflammationoleuropeinolive leaf extractPPAR-γsebum regulationSREBP-1

Identifiers

PMID42353554
PMCPMC13298046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.